Davis Polk & Wardwell advised Goldman, Sachs & Co. and J.P. Morgan Securities Inc. as joint book-running managers of a $200 million offering by NuVasive, Inc. of its 2.25% convertible senior notes due 2013. In addition, Davis Polk advised Goldman, Sachs & Co. and J.P. Morgan Securities Inc. as counterparties to call spread transactions in connection with the convertible notes offering.

NuVasive is a medical device company focused on developing products for minimally disruptive surgical treatments for the spine.

The Davis Polk corporate team included partner Alan F. Denenberg and associates Zachary Patton and Colin Sturt of the Menlo Park office. Partner Witold Balaban and associates Yan Zhang and Pierre Aidan of the New York office provided equity derivatives advice. Partner Michael Farber and associate Christine E. Graham (not yet admitted) of the New York office provided tax advice. Michael Nguyen and Jessica L. Talbot of the Menlo Park office were the legal assistants for the transaction.